Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

SIOGEN And Veeda Sign Deal on Doxorubicin

May 7, 2010 7:29 am | News | Comments

SIOGEN Biotech, a leader in silicon-based nanoparticle drug delivery and targeting, and Veeda Clinical Research, a global clinical research organisation, signed a strategic partnership agreement at the BIO conference in Chicago to develop a new nanoparticle formulation of doxorubicin to treat cancer.


Merck And ACCF Working With Bhutan on Gardasil

May 7, 2010 7:22 am | News | Comments

The Royal Government of Bhutan, Merck and the Australian Cervical Cancer Foundation (ACCF) launched a national vaccination program with GARDASIL for appropriate girls and young women in Bhutan.


FDA Approves Natazia

May 7, 2010 6:45 am | News | Comments

The Food and Drug Administration has approved a novel birth control pill from Bayer Healthcare that combines two female hormones.


Promising Results From Atherosclerosis Vaccine

May 7, 2010 6:42 am | News | Comments

A new study by researchers at the Swedish medical university Karolinska Institutet shows that the immune defence's T cells can attack the "bad" LDL cholesterol and thereby cause an inflammation that leads to atherosclerosis.


Researchers Find Candidate Gene Culprits For Chronic Pain

May 7, 2010 6:38 am | News | Comments

Chronic pain severely limits patients' quality of life and is among the cost drivers in U.S. health care. Patients can suffer pain without an apparent cause and often fail to respond to available treatments.


Scientists Define Link Between Stem Cell Regulatory Proteins

May 7, 2010 6:32 am | News | Comments

With thousands of scientists across the globe searching for ways to use adult stem cells to fight disease, there's a growing emphasis on finding the "master regulators" that guide the differentiation of stem cells.


Research Sheds Light on Milk-Renal Cell Cancer Link

May 7, 2010 6:28 am | News | Comments

While previous research had suggested that drinking milk was related to factors that may increase the risk of renal cell cancer, results of a recent study exploiting the genetic contribution to variation in milk consumption suggest that this may not be the case.


Stem Cells Could Repair Parkinson’s Damaged Brain Cells

May 7, 2010 6:23 am | News | Comments

Stem cells derived from the endometrium (uterine lining) and transplanted into the brains of laboratory mice with Parkinson's disease appear to restore functioning of brain cells damaged by the disease, according to a new study by Yale School of Medicine researchers.


Breast Cancer Metastasis Increases After Hormone Therapy

May 7, 2010 6:10 am | News | Comments

After menopause, 6 to 10 million women take hormone therapies, which are often a combination of estrogen and progestin, to replace hormones lost from inactive ovaries. Progestin is a hormone that is used to counteract the potentially negative effects of estrogen therapy on the uterus.


Possible Drug Target for Kaposi's Sarcoma

May 7, 2010 6:06 am | News | Comments

Research from the University of Leeds has identified how the virus which causes Kaposi's Sarcoma replicates and spreads – opening a door to a possible new treatment for the disease.


Colorado Senate Approves Medical Marijuana

May 7, 2010 6:01 am | by Colleen Slevin | News | Comments

A push to regulate Colorado's medical marijuana dispensaries appears to be nearing the finish line.


'The Pill' Turning 50 Years Old

May 7, 2010 5:51 am | by Carla K. Johnson | News | Comments

A world without "the pill" is unimaginable to many young women who now use it to treat acne, skip periods, improve mood and, of course, prevent pregnancy. They might be surprised to learn that U.S. officials announcing approval of the world's first oral contraceptive were uncomfortable.


real-time PCR

May 6, 2010 8:01 am | Product Releases | Comments

Life Technologies Corporation announced the expansion of its industry-leading family of real-time PCR systems with the introduction of a new high-productivity instrument.


Portable Cell Culture

May 6, 2010 7:51 am | Product Releases | Comments

Celartia Ltd. announces the introduction of its PetakaG3 Cell Culture Device, able to reduce cell culture contamination, improve portability, save space, and cut costs for a wide range of biotechnology and medical purposes.


GE Healthcare Launches HCA Award

May 6, 2010 7:44 am | News | Comments

GE Healthcare, a unit of General Electric Company, announces the launch of the first annual GE Healthcare HCA Award. The award recognizes the outstanding contribution of HCA to scientific understanding and celebrates its positive impact on data quality and quantity, and in transforming the efficiency of research and discovery.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.